MODV vs. MGX, CLOV, AXGN, AVIR, NAUT, CERS, GLUE, SERA, TERN, and VMD
Should you be buying ModivCare stock or one of its competitors? The main competitors of ModivCare include Metagenomi (MGX), Clover Health Investments (CLOV), AxoGen (AXGN), Atea Pharmaceuticals (AVIR), Nautilus Biotechnology (NAUT), Cerus (CERS), Monte Rosa Therapeutics (GLUE), Sera Prognostics (SERA), Terns Pharmaceuticals (TERN), and Viemed Healthcare (VMD). These companies are all part of the "medical" sector.
ModivCare (NASDAQ:MODV) and Metagenomi (NASDAQ:MGX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, media sentiment, institutional ownership, analyst recommendations, community ranking, dividends and risk.
ModivCare received 6 more outperform votes than Metagenomi when rated by MarketBeat users. However, 100.00% of users gave Metagenomi an outperform vote while only 38.24% of users gave ModivCare an outperform vote.
In the previous week, ModivCare's average media sentiment score of 0.00 equaled Metagenomi'saverage media sentiment score.
ModivCare currently has a consensus price target of $60.50, suggesting a potential upside of 175.50%. Metagenomi has a consensus price target of $21.40, suggesting a potential upside of 210.60%. Given Metagenomi's stronger consensus rating and higher probable upside, analysts clearly believe Metagenomi is more favorable than ModivCare.
Metagenomi has a net margin of 0.00% compared to ModivCare's net margin of -7.42%. ModivCare's return on equity of 36.50% beat Metagenomi's return on equity.
Metagenomi has lower revenue, but higher earnings than ModivCare.
Summary
Metagenomi beats ModivCare on 7 of the 11 factors compared between the two stocks.
Get ModivCare News Delivered to You Automatically
Sign up to receive the latest news and ratings for MODV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MODV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ModivCare Competitors List
Related Companies and Tools
